Literature DB >> 33330847

Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study.

Ruchika Verma1, Ramon Correa1, Virginia B Hill1, Volodymyr Statsevych1, Kaustav Bera1, Niha Beig1, Abdelkader Mahammedi1, Anant Madabhushi1, Manmeet Ahluwalia1, Pallavi Tiwari1.   

Abstract

PURPOSE: To identify radiomic features extracted from the tumor habitat on routine MR images that are prognostic for progression-free survival (PFS) and to assess their morphologic basis with corresponding histopathologic attributes in glioblastoma (GBM).
MATERIALS AND METHODS: In this retrospective study, 156 pretreatment GBM MR images (gadolinium-enhanced T1-weighted, T2-weighted, and fluid-attenuated inversion recovery [FLAIR] images) were curated. Of these 156 images, 122 were used for training (90 from The Cancer Imaging Archive and 32 from the Cleveland Clinic, acquired between December 1, 2011, and May 1, 2018) and 34 were used for validation. The validation set was obtained from the Ivy Glioblastoma Atlas Project database, for which the percentage extent of 11 histologic attributes was available on corresponding histopathologic specimens of the resected tumor. Following expert annotations of the tumor habitat (necrotic core, enhancing tumor, and FLAIR-hyperintense subcompartments), 1008 radiomic descriptors (eg, Haralick texture features, Laws energy features, co-occurrence of local anisotropic gradient orientations [CoLIAGe]) were extracted from the three MRI sequences. The top radiomic features were obtained from each subcompartment in the training set on the basis of their ability to risk-stratify patients according to PFS. These features were then concatenated to create a radiomics risk score (RRS). The RRS was independently validated on a holdout set. In addition, correlations (P < .05) of RRS features were computed, with the percentage extent of the 11 histopathologic attributes, using Spearman correlation analysis.
RESULTS: RRS yielded a concordance index of 0.80 on the validation set and constituted radiomic features, including Laws (capture edges, waves, ripple patterns) and CoLIAGe (capture disease heterogeneity) from enhancing tumor and FLAIR hyperintensity. These radiomic features were correlated with histopathologic attributes associated with disease aggressiveness in GBM, particularly tumor infiltration (P = .0044) and hyperplastic blood vessels (P = .0005).
CONCLUSION: Preliminary findings demonstrated significant associations of prognostic radiomic features with disease-specific histologic attributes, with implications for risk-stratifying patients with GBM for personalized treatment decisions. Supplemental material is available for this article. © RSNA, 2020. 2020 by the Radiological Society of North America, Inc.

Entities:  

Year:  2020        PMID: 33330847      PMCID: PMC7706886          DOI: 10.1148/ryai.2020190168

Source DB:  PubMed          Journal:  Radiol Artif Intell        ISSN: 2638-6100


  24 in total

1.  Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.

Authors:  Marianne Labussière; Blandine Boisselier; Karima Mokhtari; Anna-Luisa Di Stefano; Anais Rahimian; Marta Rossetto; Pietro Ciccarino; Olivier Saulnier; Rosina Paterra; Yannick Marie; Gaetano Finocchiaro; Marc Sanson
Journal:  Neurology       Date:  2014-08-22       Impact factor: 9.910

Review 2.  Glioblastoma niches: from the concept to the phenotypical reality.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Ilaria Bisogno; Cristina Casalone; Laura Annovazzi
Journal:  Neurol Sci       Date:  2018-05-08       Impact factor: 3.307

3.  Revealing the glioma cancer stem cell interactome, one niche at a time.

Authors:  Daniel J Silver; Justin D Lathia
Journal:  J Pathol       Date:  2018-02-02       Impact factor: 7.996

4.  Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.

Authors:  Prateek Prasanna; Jay Patel; Sasan Partovi; Anant Madabhushi; Pallavi Tiwari
Journal:  Eur Radiol       Date:  2016-10-24       Impact factor: 5.315

5.  Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis.

Authors:  Kathleen R Lamborn; Susan M Chang; Michael D Prados
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

6.  An anatomic transcriptional atlas of human glioblastoma.

Authors:  Ralph B Puchalski; Nameeta Shah; Jeremy Miller; Rachel Dalley; Steve R Nomura; Jae-Guen Yoon; Kimberly A Smith; Michael Lankerovich; Darren Bertagnolli; Kris Bickley; Andrew F Boe; Krissy Brouner; Stephanie Butler; Shiella Caldejon; Mike Chapin; Suvro Datta; Nick Dee; Tsega Desta; Tim Dolbeare; Nadezhda Dotson; Amanda Ebbert; David Feng; Xu Feng; Michael Fisher; Garrett Gee; Jeff Goldy; Lindsey Gourley; Benjamin W Gregor; Guangyu Gu; Nika Hejazinia; John Hohmann; Parvinder Hothi; Robert Howard; Kevin Joines; Ali Kriedberg; Leonard Kuan; Chris Lau; Felix Lee; Hwahyung Lee; Tracy Lemon; Fuhui Long; Naveed Mastan; Erika Mott; Chantal Murthy; Kiet Ngo; Eric Olson; Melissa Reding; Zack Riley; David Rosen; David Sandman; Nadiya Shapovalova; Clifford R Slaughterbeck; Andrew Sodt; Graham Stockdale; Aaron Szafer; Wayne Wakeman; Paul E Wohnoutka; Steven J White; Don Marsh; Robert C Rostomily; Lydia Ng; Chinh Dang; Allan Jones; Bart Keogh; Haley R Gittleman; Jill S Barnholtz-Sloan; Patrick J Cimino; Megha S Uppin; C Dirk Keene; Farrokh R Farrokhi; Justin D Lathia; Michael E Berens; Antonio Iavarone; Amy Bernard; Ed Lein; John W Phillips; Steven W Rostad; Charles Cobbs; Michael J Hawrylycz; Greg D Foltz
Journal:  Science       Date:  2018-05-11       Impact factor: 47.728

7.  Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe): A new radiomics descriptor.

Authors:  Prateek Prasanna; Pallavi Tiwari; Anant Madabhushi
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

8.  Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.

Authors:  Nathaniel M Braman; Maryam Etesami; Prateek Prasanna; Christina Dubchuk; Hannah Gilmore; Pallavi Tiwari; Donna Plecha; Anant Madabhushi
Journal:  Breast Cancer Res       Date:  2017-05-18       Impact factor: 6.466

9.  Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in Glioblastoma.

Authors:  Aya Ishii; Tokuhiro Kimura; Hirokazu Sadahiro; Hiroo Kawano; Keiyo Takubo; Michiyasu Suzuki; Eiji Ikeda
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

10.  Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings.

Authors:  Gregory Penzias; Asha Singanamalli; Robin Elliott; Jay Gollamudi; Natalie Shih; Michael Feldman; Phillip D Stricker; Warick Delprado; Sarita Tiwari; Maret Böhm; Anne-Maree Haynes; Lee Ponsky; Pingfu Fu; Pallavi Tiwari; Satish Viswanath; Anant Madabhushi
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

View more
  8 in total

Review 1.  Radiomics for precision medicine in glioblastoma.

Authors:  Kiran Aftab; Faiqa Binte Aamir; Saad Mallick; Fatima Mubarak; Whitney B Pope; Tom Mikkelsen; Jack P Rock; Syed Ather Enam
Journal:  J Neurooncol       Date:  2022-01-12       Impact factor: 4.130

2.  Editorial for "Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics".

Authors:  Satish E Viswanath
Journal:  J Magn Reson Imaging       Date:  2022-03-04       Impact factor: 5.119

Review 3.  MRI biomarkers in neuro-oncology.

Authors:  Marion Smits
Journal:  Nat Rev Neurol       Date:  2021-06-20       Impact factor: 42.937

Review 4.  Advancements in Neuroimaging to Unravel Biological and Molecular Features of Brain Tumors.

Authors:  Francesco Sanvito; Antonella Castellano; Andrea Falini
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

5.  Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study.

Authors:  Michele Bailo; Nicolò Pecco; Marcella Callea; Paola Scifo; Filippo Gagliardi; Luca Presotto; Valentino Bettinardi; Federico Fallanca; Paola Mapelli; Luigi Gianolli; Claudio Doglioni; Nicoletta Anzalone; Maria Picchio; Pietro Mortini; Andrea Falini; Antonella Castellano
Journal:  Front Neurosci       Date:  2022-07-13       Impact factor: 5.152

6.  Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients.

Authors:  Pengfei Guo; Mathias Unberath; Hye-Young Heo; Charles G Eberhart; Michael Lim; Jaishri O Blakeley; Shanshan Jiang
Journal:  Neuroimage Clin       Date:  2022-07-18       Impact factor: 4.891

7.  Habitat radiomics analysis of pet/ct imaging in high-grade serous ovarian cancer: Application to Ki-67 status and progression-free survival.

Authors:  Xinghao Wang; Chen Xu; Marcin Grzegorzek; Hongzan Sun
Journal:  Front Physiol       Date:  2022-08-25       Impact factor: 4.755

Review 8.  Artificial intelligence in the radiomic analysis of glioblastomas: A review, taxonomy, and perspective.

Authors:  Ming Zhu; Sijia Li; Yu Kuang; Virginia B Hill; Amy B Heimberger; Lijie Zhai; Shengjie Zhai
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.